Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : CardioDynamics (CDIC) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (123)	6/26/2001 5:06:26 PM
From: Mark Bong	Respond to of 201

GE INTRODUCES THE WORLD'S FIRST NON-INVASIVE HEMODYNAMIC PATIENT MONITORING SYSTEM WITH CARDIODYNAMIC'S ICG TECHNOLOGY I heard in the CC that GE already has many of these sold, so it should boost the next Q Net Income, hopefully to a profitable level. Mark GE Medical Systems Information Technologies, the global leader in Patient Monitoring, introduced the world's first and only patient monitoring system capable of non-invasively acquiring and displaying hemodynamic (blood flow) information. This advancement will provide clinicians with critical information about the mechanical performance of a patient's heart without an invasive procedure, so they can provide patients with a fast, confident assessment and diagnosis. The new system unites GE's Solar® 8000 patient monitor and CardioDynamics (Nasdaq: CDIC - news) innovative BioZ® Impedance Cardiography (ICG) technology to provide first-of-its-kind monitoring technology to hospitals worldwide. The U.S. Food and Drug Administration recently granted clearance for GE's new BioZ® ICG module, and the system is now commercially available. "GE conducted a survey of 700 physicians and nurses around the world," said Kevin King, vice president of Clinical Systems at GE Medical Systems Information Technologies. "The majority told us that non-invasive hemodynamic monitoring was their number one unmet need." Before the advent of CardioDynamics' BioZ ICG technology, clinicians had to subjectively treat patients without necessary hemodynamic information or utilize an invasive, and costly procedure called a Pulmonary Artery Catheter (PAC). The real-time information provided by GE's Solar monitors with the ICG feature will allow clinicians to more quickly access hemodynamic information traditionally provided by a PAC, without the invasive procedure. According to King, GE's exciting new offering is the result of a 12-month collaborative technology effort between GE and CardioDynamics. The company expects to install approximately 2000 of the new Solar monitoring systems with ICG capabilities worldwide by the end of 2002. Contact: Jennifer Christiansen, 414/362-2544, jennifer.christiansen@med.ge.com

To: Biomaven who wrote (123)	11/20/2001 2:46:55 AM
From: tuck	Read Replies (2) \| Respond to of 201

Peter, Do you still watch CDIC? I am watching very closely now. >>>>SAN DIEGO, Nov 13, 2001 /PRNewswire via COMTEX/ -- CardioDynamics International Corporation (Nasdaq: CDIC chart, msgs), the innovator and market leader of Impedance Cardiography (ICG) technology and manufacturer of BioZ(R) noninvasive digital cardiac function monitoring systems, today announced that the American Medical Association (AMA) has issued a Current Procedural Terminology (CPT) code for its ICG technology. The new CPT code, 93701, is specific for the Company's ICG technology and may be used alone or in conjunction with other diagnostic cardiovascular tests when submitting for reimbursement of claims to either Medicare or private insurers. The new CPT code was published in the Federal Register, is included in Medicare's 2002 database, and becomes effective January 1, 2002. According to the AMA, healthcare providers use the CPT code when reporting medical procedures and services under public and private health insurance programs, and for administrative management in claims processing and developing guidelines for medical care review. Previously, healthcare providers utilized generic codes for private insurance and a lower level code for Medicare. The newly issued CPT code will simplify billing procedures for the medical community. "We are very pleased to receive our own unique CPT Code for our ICG technology, stated Michael K. Perry, CardioDynamics' Chief Executive Officer. "Receipt of this code from the AMA reflects our technology's acceptance and importance as a key tool to the medical community. Our CPT code now allows customers to perform BioZ monitoring with the knowledge that the reimbursement filing and payment has been standardized." Perry added, "The CPT code is another step toward facilitating market penetration and broad clinical use of our technology and ultimately establishing Impedance Cardiography as a standard of care for a broad range of patients, including those with congestive heart failure and high blood pressure." The Company also announced that it is exhibiting its BioZ ICG technology at the American Heart Association 2001 Scientific Sessions in Anaheim, California being held November 12-14, 2001. With an estimated 5,000 cardiologists in attendance, it is an excellent opportunity for the Company to obtain sales and sales leads and also highlight the year's product development and clinical application progress.<< snip Cheers, Tuck